瘰疬宁治疗淋巴结核临床研究

Clinical Research of Lymphatic Treated by Scrofula Ning

目的:观察瘰疬宁治疗淋巴结核的临床疗效。方法:将260例患者按随机、双盲、平行对照的方法分为对照组和试验组,每组各130例。对照组采用抗结核西药三联(安慰剂+异烟肼+利福平+乙胺丁醇)治疗;试验组在对照组治疗基础上加用瘰疬宁治疗。两组均治疗6个月后观察疗效及安全性指标。结果:治疗后试验组有效率为96.15%,对照组有效率为76.15%。两组疗效比较,差异有统计学意义,治疗组优于对照组(P≤0.01),其中以肝郁痰凝证疗效最佳(P≤0.01);治疗后两组ALT、AST比较,差异无统计学意义(P>0.05)。结论:瘰疬宁是一种治疗淋巴结核有效、安全的治疗药物。

Objective：To investigate the clinical efficacy of Scrofula Ning treatment of scrofula. Methods ：260 patients randomized,double-blind,parallel-group approach divided into control and experimental groups ,each group 130 cases. The control group with triple anti- TB medicine（ placebo ＋ rifampicin ＋ isoniazid ＋ ethambutol） treatment;trial group were treated based on treatment with scrofula Ning. Both groups were observed after 6 months of treatment efficacy and safety indicators. Results lAfter treatment,the test group was 96. 15% ,the control group was 76.15%. Comparison of two groups, the difference was statistically significant, the treatment group than the control group（P~〈0.01 ） ,which permits liver Tanning best effect （P ~〈0.01 ） ;groups after treatment ALT, AST, the difference was no statistically significant（ P 〉 0.05 ）. Conclusion：scrofula Ning is a therapeutic lymphatic effective and safe therapy.